Brief: Cipher Pharmaceuticals Q2 loss per share c$0.13

Cipher Pharmaceuticals

10/08/2016 12:00

Aug 10 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO  
    * Cipher pharmaceuticals reports q2 2016 results highlighted 
by 32% revenue growth and $3.1 million cash from operations 
    * Cipher pharmaceuticals inc qtrly total revenue of $11.7 
million, an increase of 32% from $8.8 million in q2 2015 
    * Q2 loss per share c$0.13 
 
Source text for Eikon:  ID:nCNW4XqzQa  
Further company coverage:  CPH.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))